Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Foster Stockbroking Pty Ltd. Gives Alexium a Buy Rating in Latest Report

RPT

PERTH, AUSTRALIA and GREER, SC--(Marketwired - May 26, 2015) -  Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) is pleased to announce that Foster Stockbroking has given Alexium a buy rating in its latest report based on several factors, including the strength of the sales pipeline and a potential annual revenue of $10 million for 2015.

The report can be found on Alexium's website under investor research or at the following link: http://alexiuminternational.com/wp-content/uploads/2015/05/Foster-Stockbroking-Report-May-2015.pdf

For more information visit: www.alexiuminternational.com.

About Alexium

Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatment are currently marketed for different fabric markets under the Alexiflam™, Alexiflam-NF™, Alexiflam-SYN™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.

U.S Contact:
Julie Patrick
Marketing & PR Specialist
jpatrick@alexiuminternational.com
U.S.: +1 864.908.6793

U.S. R&D Center:
8 Distribution Court
Greer, SC 29650
T: +1 864.416.1060
F: +1 864.752.6465

U.S. Corporate Office:
148 Milestone Way
Greenville, SC 29615
T: +1 864.603.1165
F: +1 864.752.6465



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today